The current and future landscape of RNA-based therapies and diagnostics
Catherine A. Freije, Virginia Arechavala‐Gomeza
3 citationsCommunications Medicine
Virginia Arechavala‐Gomeza
Informations fournies par OpenAlex. Research Africa ne déduit ni nationalité, ni poste, ni coordonnées personnelles.
72Publications signalées
4149Citations signalées
2Affiliations récentes
Institutions déclarées
Domaines associés
Muscle Physiology and DisordersNeurogenetic and Muscular Disorders ResearchRNA Interference and Gene DeliveryCRISPR and Genetic EngineeringRNA Research and Splicing
Publications récentes
Ending publication bias: A values-based approach to surface null and negative results
Stephen Curry, Eunice Mercado-Lara, Virginia Arechavala‐Gomeza, C. Glenn Begley et autres
14 citationsPLoS Biology
Characterization of DMPK and MBNL1 expression in cell models of myotonic dystrophy: a platform for drug screening
Andrea López‐Martínez, Sergio Martín‐González, Noemi Torres‐Conde, Nahia Alcalá-Manso et autres
1 citationNAR Molecular Medicine
Collablots: Quantification of Collagen VI Levels and Its Structural Disorganisation in Cell Cultures From Patients With Collagen VI‐Related Dystrophies
Nadia Osegui‐Barcenilla, Maria Sendino, Sergio Martín‐González, Itziar González‐Moro et autres
0 citationsNeuropathology and Applied Neurobiology
Antisense RNA therapies for muscular dystrophies
Virginia Arechavala‐Gomeza, Andrea López‐Martínez, Annemieke Aartsma‐Rus
10 citationsJournal of Neuromuscular Diseases
Characterisation of DMPK and MBNL1 expression in cell models of Myotonic Dystrophy: A platform for drug screening
Andrea López‐Martínez, Sergio Martín‐González, Noemi Torres‐Conde, Nahia Alcalá-Manso et autres
0 citationsbioRxiv (Cold Spring Harbor Laboratory)
Collablots: Quantification of collagen VI levels and its structural disorganisation in cell cultures from patients with collagen VI-related dystrophies
Nadia Osegui‐Barcenilla, Maria Sendino, Sergio Martín‐González, Ainhoa Benito‐Agustino et autres
0 citationsbioRxiv (Cold Spring Harbor Laboratory)
Deletion of exons 45 to 55 in the DMD gene: from the therapeutic perspective to the in vitro model
Javier Poyatos‐García, Patricia Soblechero‐Martín, Alessandro Liquori, Andrea López‐Martínez et autres
1 citationSkeletal Muscle
Progress and harmonization of gene editing to treat human diseases: Proceeding of COST Action CA21113 GenE-HumDi
Alessia Cavazza, Ayal Hendel, Rasmus O. Bak, Paula Rı́o et autres
11 citationsMolecular Therapy — Nucleic Acids
Deletion of exons 45 to 55 in the DMD gene: from the therapeutic perspective to the in vitro model
Javier Poyatos‐García, Patricia Soblechero‐Martín, Alessandro Liquori, Andrea López‐Martínez et autres
0 citationsbioRxiv (Cold Spring Harbor Laboratory)
Experimental Model Systems Used in the Preclinical Development of Nucleic Acid Therapeutics
Haiyan Zhou, Virginia Arechavala‐Gomeza, Alejandro Garanto
4 citationsNucleic Acid Therapeutics
Considerations in the Preclinical Assessment of the Safety of Antisense Oligonucleotides
Aurélie Goyenvalle, C. Jimenez‐Mallebrera, Willeke van Roon‐Mom, Sabine Sewing et autres
93 citationsNucleic Acid Therapeutics
BNTIC News n’est pas le producteur de ces données. Recherche à la demande dans Crossref et Europe PMC, sans clé ; OpenAlex reste optionnel. Aucun service payant requis, aucune réponse conservée. Sources et limites.